Microbix Biosystems Inc.

MBXBF · OTC
Analyze with AI
9/30/2025
9/30/2024
9/30/2023
9/30/2022
Operating Activities
Net Income-$1,612$3,520-$39$1,789
Dep. & Amort.$1,278$1,613$1,157$1,036
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$714$735$650
Change in WC-$545-$1,774-$220-$340
Other Non-Cash$822$274-$2,728$331
Operating Cash Flow-$58$4,348-$1,095$3,465
Investing Activities
PP&E Inv.-$572-$1,636-$1,016-$2,026
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0-$271$0$0
Investing Cash Flow-$572-$1,907-$1,016-$2,026
Financing Activities
Debt Repay.-$609-$522$1,239-$1,382
Stock Issued$2,022$0$0$3,444
Stock Repurch.-$1,243-$925-$1,115$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$151$364$105$3,444
Financing Cash Flow$19-$1,084$229$2,062
Forex Effect-$273$0$0$0
Net Chg. in Cash-$884$1,357-$1,882$3,502
Supplemental Information
Beg. Cash$9,581$11,606$13,488$9,986
End Cash$8,697$12,963$11,606$13,488
Free Cash Flow-$630$2,441-$2,111$1,440